研究成果以第一或通讯作者在Phytomedicine, Journal of Ethnopharmacology, Journal of Agricultural and Food Chemistry等期刊发表SCI论文53篇，获授权发明专利40项，以副主编出版著作7部，制定地方标准1个，获4个创新药物临床试验批件，获吉林省科学技术一等奖3项（排名第2、2和15）、二等奖3项（排名第2、2和3），获吉林省自然科学学术成果一等奖1项（排名第1），获中国产学研合作创新成果二等奖1项（排名第2）。作为项目负责人主持中国博士后科学基金一等资助金项目1项，吉林省省级科研重点项目10余项。现任人参创新药物开发国家地方联合工程研究中心副主任、吉林省人参（西洋参）创新药物开发工程研究中心主任、吉林省中成药二次开发科技创新中心主任、吉林省中医药管理局中药创新药重点研究室主任。获吉林省“长白英才计划”杰出人才团队带头人、吉林省高层次B类人才、吉林省第七批拔尖创新人才第三层次、吉林省企业“科创专员（科创副总）”等荣誉或称号。
5篇代表性论文：
(1) Caixia Wang, Zhuoqiao Li, Linxuan Liu, Wang jia, Xiaoyu Geng, Hanlin Liu, Cuizhu Wang, Yuanyuan Wu, Hongqiang Lin*, Jinping Liu*. Oleanolic acid 28-O-β-D-glucopyranoside alleviates TNBS-induced ulcerative colitis in rat by regulating Nrf2/x-CT/GPX4-mediated ferroptosis, Journal of Ethnopharmacology, 2025, 353: 120369. (IF=5.4, 中科院一区论文)
(2) Caixia Wang, Hui Yu, Zhuoqiao Li, Junzhe Wu, Peng Gao, Shanmei He, Daohao Tang, Qianyun Wang, Hanlin Liu, Haoming Lv, Jinping Liu*. Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology, Phytomedicine, 2024, 128: 155366. (IF=6.7, 中科院一区论文)
(3) Yunhe Liu, Junzhe Wu, Luying Tan, Zhuoqiao Li, Peng Gao, Shanmei He, Qianyun Wang, Daohao Tang, Cuizhu Wang, Fang Wang, Pingya Li, Jinping Liu*. (-)-Syringaresinol attenuates ulcerative colitis by improving intestinal epithelial barrier function and inhibiting inflammatory responses, Phytomedicine, 2024, 124: 155292. (IF=6.7, 中科院一区论文)
(4) Yaru Wang, Changcheng Li, Jingyi Chen, Xiaoli Cui, Binghuan Wang, Yuezeng Wang, Dayu Wang, Jinping Liu*, Jing Li*. Pyxinol fatty acid ester derivatives J16 against AKI by selectively promoting M1 transition to M2c macrophages, Journal of Agricultural and Food Chemistry, 2024, 1520-5118. (IF=5.7, 中科院一区论文)
(5) Longhai Jin#, Jinping Liu#, Shu Wang, Linxian Zhao, Jiannan Li*. Evaluation of 20(S)- ginsenoside Rg3 loaded hydrogel for the treatment of perianal ulcer in a rat model, Journal of Ginseng Research, 2022,46(6): 771-779. (IF=6.3, 中科院一区论文)
